| EDWARDS LIFESCIENCES |
| USA |
| Gesundheit |
| US28176E1082 / 936853 |
| EWL (Frankfurt) / EW (NYSE) |
| FRA:EWL, ETR:EWL, EWL:GR, NYSE:EW |
| S&P500 |
| https://www.edwards.com/ |
|
Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing innovative medical technologies for structural he..
>Volltext.. |
| 41120.96 Mio. EUR |
| 38549.56 Mio. EUR |
| 5425.66 Mio. EUR |
| 1642.89 Mio. EUR |
| 925.81 Mio. EUR |
| 1.59 EUR |
| 605.01 Mio. EUR |
| 2105.79 Mio. EUR |
| - |
| 2.61 |
| 6.56% |
| 13.43% |
| - |
| - |
| - |
| EDWARDS LIFESCIENCES, EDWARDS LIFE |
| 22.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|